Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens
D De Novellis, R Fontana, B Serio, E Vaccaro… - Cancer …, 2024 - Wiley Online Library
Background Viral reactivations are frequent in hematologial patients due to their cancer‐
related and drug‐induced immunosuppressive status. Daratumumab, an anti‐CD38 …
related and drug‐induced immunosuppressive status. Daratumumab, an anti‐CD38 …